London, April 7:  The United Kingdom's drug regulator says the AstraZeneca vaccine has huge benefits but people under 30 will be offered another product due to a rare blood clot risk. The Medicines and Healthcare Products Regulatory Agency said Wednesday that while it is studying the possible connection between AstraZeneca's coronavirus vaccine and rare blood clots, the Pfizer and Moderna vaccines should be offered to people in that age group.

Dr June Raine, the head of he MHRA, says that the benefits “continue to outweigh the risks for the vast majority of people.” The decision was announced soon after the European Union's drug regulator said it had found a “possible link” between the AstraZeneca coronavirus vaccine and a rare clotting disorder. COVID-19 Vaccination: UK Regulator Reports 30 Clot Cases Linked to AstraZeneca Jab.

But that agency did not recommend any new restrictions on the vaccine for people 18 and over, saying the benefits of the shot still outweigh risks. (AP)

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)